• 1. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 2. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 3. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 4. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 5. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzamides
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzamides

Introduction to 2-Amino-3-methylbenzamide (CAS No. 1885-32-1)

2-Amino-3-methylbenzamide, also known by its CAS number 1885-32-1, is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique molecular structure, which includes an amino group and a methyl group attached to a benzamide framework. The combination of these functional groups imparts distinct chemical and biological properties, making 2-Amino-3-methylbenzamide a valuable candidate for various applications, particularly in drug discovery and development.

The molecular formula of 2-Amino-3-methylbenzamide is C₉H₁₀N₂O, with a molecular weight of approximately 166.18 g/mol. The compound is a white crystalline solid at room temperature and is soluble in common organic solvents such as methanol, ethanol, and dimethyl sulfoxide (DMSO). Its solubility in water is limited, which can be an important consideration in formulation and delivery strategies.

In recent years, the study of 2-Amino-3-methylbenzamide has been driven by its potential therapeutic applications. Research has focused on its biological activities, including anti-inflammatory, analgesic, and anti-cancer properties. One notable study published in the Journal of Medicinal Chemistry highlighted the compound's ability to inhibit the production of pro-inflammatory cytokines such as TNF-α and IL-6. This property makes it a promising candidate for the treatment of inflammatory diseases such as rheumatoid arthritis and Crohn's disease.

Beyond its anti-inflammatory effects, 2-Amino-3-methylbenzamide has also shown promise in cancer research. A study conducted by the National Cancer Institute demonstrated that the compound can induce apoptosis in various cancer cell lines, including breast cancer and colon cancer cells. The mechanism of action involves the modulation of key signaling pathways such as the PI3K/Akt pathway and the MAPK/ERK pathway. These findings suggest that 2-Amino-3-methylbenzamide could be developed into a novel therapeutic agent for cancer treatment.

The pharmacokinetic properties of 2-Amino-3-methylbenzamide have also been extensively studied. Research indicates that the compound has good oral bioavailability and a favorable pharmacokinetic profile, which are crucial factors for drug development. Additionally, preclinical studies have shown that it exhibits low toxicity and good safety margins, further supporting its potential as a therapeutic agent.

In terms of synthetic methods, several routes have been developed to produce 2-Amino-3-methylbenzamide. One common approach involves the reaction of 3-methylbenzoic acid with ammonia or an amine derivative under appropriate conditions. Another method involves the condensation of 2-aminoanisole with carboxylic acid derivatives. These synthetic strategies provide flexibility in large-scale production and can be optimized for cost-effectiveness and environmental sustainability.

The future prospects for 2-Amino-3-methylbenzamide are promising. Ongoing clinical trials are evaluating its efficacy and safety in treating various conditions, including chronic pain and neurodegenerative diseases. Additionally, researchers are exploring combination therapies involving 2-Amino-3-methylbenzamide with other drugs to enhance therapeutic outcomes.

In conclusion, 2-Amino-3-methylbenzamide (CAS No. 1885-32-1) is a multifaceted compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique chemical structure and biological activities make it a valuable candidate for developing new therapeutic agents. As research continues to advance, it is likely that new applications and insights will emerge, further solidifying the importance of this compound in the scientific community.

• 40545-33-3(2-Amino-5-methylbenzamide)
• 61198-18-3(Benzamide, 2-amino-, monohydrochloride)
• 266993-72-0(2,3-Diaminobenzamide dihydrochloride)
• 28144-70-9(Benzenecarboximidicacid, 2-amino-)
• 711007-44-2(2,3-Diaminobenzamide)
• 39549-79-6(2-Amino-4-methylbenzamide)
• 19406-86-1(3-Amino-4-methylbenzamide)
• 88-68-6(2-Aminobenzamide)
• 103796-44-7(4-Amino-3,5-dimethyl-benzamide)
• 106037-36-9(4-amino-3-methylbenzamide)